当前位置： SCI文献检索 > Human Vaccines & Immunotherapeutics期刊下所有文献 > A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

Abstract：

:The licensed meningococcal serogroup B vaccine, 4CMenB (Bexsero(®)), contains recombinant membrane proteins (rMenB) and outer membrane vesicles (OMV) of the New Zealand serogroup B strain. We investigated whether reducing the OMV and/or protein content influences 4CMenB immunogenicity and reactogenicity in healthy two month-old infants. Six formulations were studied: 4CMenB, rMenB with 0, ¼ or ½ the OMV dose in 4CMenB, a half-dose of 4CMenB or a prelicensure formulation of 4CMenB, as a 4-dose primary/booster series, concomitantly with routine vaccines (DTaP-HBV-IPV/Hib and 7-valent pneumococcal conjugate) at 2, 3, 4 and 12 months of age. Immunogenicity was assessed as serum bactericidal activity measured with human complement (hSBA) against indicator strains for Men B vaccine antigens before and after the 2,3,4-month series and 12-month dose. Parents recorded solicited reactions for 7 days after each vaccination, and any adverse events throughout the study period. All formulations elicited robust immune response against rMenB components at 5 months, there was some evidence of OMV and protein dose-dependence for Men B indicator strains tested. Titers waned up to the 12-month dose, which elicited further strong responses, which were still OMV and protein dose-dependent. Groups with no, or low-dose OMV displayed slightly lower reactogenicity profiles, but all formulations were generally well-tolerated, high fever was rare and transient, and only three transient SAEs were considered possibly vaccine-related. Decreasing or removing the OMV content reduced reactogenicity of 4CMenB to a certain extent, but had an unacceptable negative impact on the immunogenicity profile. Trial: Clinicaltrials.gov NCT00937521.

journal_name

Hum Vaccin Immunother

journal_title

Human vaccines & immunotherapeutics

authors

Esposito S,Prymula R,Zuccotti GV,Xie F,Barone M,Dull PM,Toneatto D

doi

10.4161/hv.29218

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

2005-14

issue

7

eissn

2164-5515

issn

2164-554X

journal_volume

10

pub_type

杂志文章,多中心研究,随机对照试验

相关文献

Human Vaccines & Immunotherapeutics文献大全
  • Immunization services offered in Québec (Canada) pharmacies.

    abstract：:Canadian Pharmacists are easy to reach. Although Québec pharmacists are not allowed to administer vaccines, they can: (1) promote vaccination, (2) counsel patients on vaccination, (3) sell vaccines and (4) provide vaccine administration by a nurse. Our objectives were to describe immunization services given in Québec ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.25186

    authors： Sauvageau C,Dubé E,Bradet R,Mondor M,Lavoie F,Moisan J

    更新日期：2013-09-01 00:00:00

  • Tetanus toxoid vaccine: elimination of neonatal tetanus in selected states of India.

    abstract：:Tetanus is caused by a neurotoxin produced by Clostridium tetani (C. tetani), a spore-forming bacterium. Infection begins when tetanus spores are introduced into damaged tissue. Tetanus is characterized by muscle rigidity and painful muscle spasms caused by tetanus toxin's blockade of inhibitory neurons that normally ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.21145

    authors： Verma R,Khanna P

    更新日期：2012-10-01 00:00:00

  • Non-specific effects of vaccinations in high-income settings: How to address the issue?

    abstract：:"Non-specific effects" of vaccines go beyond the specific protective effects against the targeted diseases. They, if real, could theoretically be beneficial, neutral or negative. This article intends to answer the following questions: Do the non-specific effects of vaccines exist? Almost certainly yes, and they can be...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1502520

    authors： Donzelli A,Schivalocchi A,Giudicatti G

    更新日期：2018-01-01 00:00:00

  • Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules.

    abstract：:The 4-component vaccine 4CMenB, developed against invasive disease caused by meningococcal serogroup B, is approved for use in infants in several countries worldwide. 4CMenB is mostly used as 3 + 1 schedule, except for the UK, where a 2 + 1 schedule is used, and where the vaccine showed an effectiveness of 82.9%. Here...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1537756

    authors： Biolchi A,Tomei S,Santini L,Welsch JA,Toneatto D,Gaitatzis N,Bai X,Borrow R,Giuliani MM,Mori E,Pizza M

    更新日期：2019-01-01 00:00:00

  • Modeling the hepatitis A epidemiological transition in Brazil and Mexico.

    abstract：BACKGROUND:Many low- to middle-income countries have completed or are in the process of transitioning from high or intermediate to low endemicity for hepatitis A virus (HAV). Because the risk of severe hepatitis A disease increases with age at infection, decreased incidence that leaves older children and adults suscept...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1323158

    authors： Van Effelterre T,Guignard A,Marano C,Rojas R,Jacobsen KH

    更新日期：2017-08-03 00:00:00

  • Mixing of diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in a population of children in managed care.

    abstract：:The Advisory Committee on Immunization Practices recommends administering diphtheria, tetanus and acellular pertussis (DTaP) vaccines to children at 2, 4, 6, 15-18 months, and 4-6 y of age; preferably with the same-brand vaccine for the whole series. We estimated age-appropriate DTaP dose completion and the proportion...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/21645515.2014.985506

    authors： Masseria C,Buikema AR,Liu F,Krishnarajah G

    更新日期：2015-01-01 00:00:00

  • Vaccination among Polish university students. Knowledge, beliefs and anti-vaccination attitudes.

    abstract：:Anti-vaccination movement has existed as long as the vaccines themselves, but its mode of action and social influences evolved over time. Such attitude with no doubt has negative impact on vaccination rates and eradication of infectious diseases. In this study, we used an online survey to examine vaccination attitudes...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1365994

    authors： Zarobkiewicz MK,Zimecka A,Zuzak T,Cieślak D,Roliński J,Grywalska E

    更新日期：2017-11-02 00:00:00

  • Influenza vaccination coverage rate in children: reasons for a failure and how to go forward.

    abstract：:Based on an increasingly extensive literature expressing the large interest in the field, this paper gives an overview of different aspects of influenza prevention in children. It relies on paradoxes. First, the heaviest part of the burden is well demonstrated in the youngest infants by numerous epidemiological data e...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.8.1.18278

    authors： Olivier CW

    更新日期：2012-01-01 00:00:00

  • Use of adjuvants for immunotherapy.

    abstract：:Cancer vaccines are designed to stimulate the body's immune system to kill tumor cells. To improve their immunogenicity, vaccine antigens must be combined with adjuvants which are able to stimulate the innate immunity and potentiate the adaptive immune response. In the last years a new generation of adjuvants mimickin...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1321725

    authors： Circelli L,Tornesello M,Buonaguro FM,Buonaguro L

    更新日期：2017-08-03 00:00:00

  • Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season.

    abstract：:Thanks to the screening method, we estimated among target groups the 2010/2011 field vaccine effectiveness (FVE) against laboratory confirmed influenza cases seen in general practice. We also compared the values of FVE estimations obtained by using three sources of the population vaccination coverage (VC) based on thr...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.25513

    authors： Falchi A,Souty C,Grisoni ML,Mosnier A,Hanslik T,Daviaud I,Varesi L,Kerneis S,Carrat F,Blanchon T

    更新日期：2013-11-01 00:00:00

  • A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.

    abstract：:A new live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) has been developed based on innovative technology to give protection against JE with an improved immunogenicity and safety profile. In this phase 3, observer-blind study, 274 children aged 12-24 months were randomized 1:1 to receive one dose of...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.4161/hv.29743

    authors： Kim DS,Houillon G,Jang GC,Cha SH,Choi SH,Lee J,Kim HM,Kim JH,Kang JH,Kim JH,Kim KH,Kim HS,Bang J,Naimi Z,Bosch-Castells V,Boaz M,Bouckenooghe A

    更新日期：2014-01-01 00:00:00

  • Polio vaccination campaign in Pakistan: a step towards eradication or still a challenge in hand?

    abstract：:Polio is an acute viral disease that is still endemic in Pakistan. The polio vaccination program is facing many challenges that result in an increased number of new cases. The success of polio vaccination has been threatened in different parts of Pakistan. In the past, the immunization program was affected by differen...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1717152

    authors： Ahmad T,Khan M,Musa TH,Hui J

    更新日期：2020-06-02 00:00:00

  • Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries.

    abstract：:Novel coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus, which belongs to the genus Coronaviridae with its high mutation rate. From the current perspective, we discuss the current status of COVID-19, new challenges, and potential interventions to control the pandemic in developing counties such as ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1766939

    authors： Anjum FR,Anam S,Rahman SU

    更新日期：2020-10-02 00:00:00

  • Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.

    abstract：:Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We assessed racial/ethnic and gender disparities in knowledge and awareness of HPV and the HPV vaccine among US adults. METHODS:Data from the Health Information National Trends Survey 4 Cycle 3 (September - December 2013) and Cycle 4 (A...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1363133

    authors： Adjei Boakye E,Tobo BB,Rojek RP,Mohammed KA,Geneus CJ,Osazuwa-Peters N

    更新日期：2017-11-02 00:00:00

  • Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China.

    abstract：:Hepatitis B virus (HBV) remains a challenging public-health issue in China. Hepatitis B carriers and patients suffer not only physically but also experience strong discrimination and stigma. China's rural population is 629 million. Thus, there is a great need to understand the situation surrounding HBV-related discrim...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1069932

    authors： Yu L,Wang J,Zhu D,Leng A,Wangen KR

    更新日期：2016-01-01 00:00:00

  • Percentages of PD-1+CD4+T cells and PD-L1+DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia.

    abstract：:The present study is to measure the expression of programmed death (PD)-1 / programmed death ligand-1 (PD-L1) negative costimulatory molecules, soluble format sPD-1 in patients with immune thrombocytopenia (ITP), and to investigate their correlation with the secretion of cytokines. A total of 35 patients with ITP were...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2017.1342913

    authors： Wang Y,Pang N,Wang X,Liu Y,Wang X,Wang L,Sun M,Yasen H,Zhao F,Fan W,Guo X,Ding J

    更新日期：2018-04-03 00:00:00

  • Premature B-cell senescence as a consequence of chronic immune activation.

    abstract：:Similar features between the immune system of healthy elderly people and of younger individuals subjected to conditions of chronic immune activation are progressively being observed. This is raising the hypothesis that chronic immune activation may cause the premature aging of the immune system. Here we dissect this t...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.28698

    authors： Palma P,Rinaldi S,Cotugno N,Santilli V,Pahwa S,Rossi P,Cagigi A

    更新日期：2014-01-01 00:00:00

  • Dendritic cell targeted vaccines: Recent progresses and challenges.

    abstract：:Dendritic cells (DCs) are known to be a set of morphology, structure and function of heterogeneous professional antigen presenting cells (APCs), as well as the strongest functional antigen presenting cells, which can absorb, process and present antigens. As the key regulators of innate and adaptive immune responses, D...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1105415

    authors： Chen P,Liu X,Sun Y,Zhou P,Wang Y,Zhang Y

    更新日期：2016-03-03 00:00:00

  • Two cases of disseminated BCG disease following vaccination in the same family: case reports and review of the literature in China.

    abstract：:Disseminated bacillus Calmette-Guérin (BCG) disease is a rare and serious adverse event following immunization (AEFI) with BCG. Here, we reported two cases of disseminated BCG disease in the same family and reviewed the literature to identify another 35 cases in China. The average age at onset was 3.7 ± 2.1 months amo...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2020.1819102

    authors： Wang J,Wu QS,Jiang MB,Xu ZH

    更新日期：2020-10-20 00:00:00

  • Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.

    abstract：:In the clinical trials of the quadrivalent human papillomavirus (qHPV) vaccine, antibodies were measured by a competitive Luminex immunoassay (HPV-4 cLIA). A nine-valent HPV (9vHPV) vaccine targeting the types in the qHPV vaccine (HPV6/11/16/18), as well as 5 of the next most frequent HPV types found in cervical cance...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.4161/hv.29205

    authors： Roberts C,Green T,Hess E,Matys K,Brown MJ,Haupt RM,Luxembourg A,Vuocolo S,Saah A,Antonello J

    更新日期：2014-01-01 00:00:00

  • Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques.

    abstract：:HIV sequence diversity and the propensity of eliciting immunodominant responses targeting inessential variable regions are hurdles in the development of an effective AIDS vaccine. We developed a DNA vaccine comprising conserved elements (CE) of SIV p27Gag and HIV-1 Env and found that priming vaccination with CE DNA is...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2018.1489949

    authors： Hu X,Lu Z,Valentin A,Rosati M,Broderick KE,Sardesai NY,Marx PA,Mullins JI,Pavlakis GN,Felber BK

    更新日期：2018-01-01 00:00:00

  • Vaccinations-Between free will and coercion.

    abstract：:Dynamically changing social situation associated with migrations, increasing freedom rights, popularity of anti-vaccine movements and the resulting from that decrease in herd immunity, forces the medical society and the governments of various countries to reflect on the attitude toward vaccinations. Issues of freedoms...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2016.1162936

    authors： Patryn RK,Zagaja A

    更新日期：2016-08-02 00:00:00

  • Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.

    abstract：:Vaccines dramatically reduce infection-related morbidity and mortality. Determining factors that modulate the host response is key to rational vaccine design and demands unsupervised analysis. To longitudinally resolve influenza-specific humoral immune response dynamics we constructed vaccine response profiles of infl...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2015.1008930

    authors： Berger CT,Greiff V,Mehling M,Fritz S,Meier MA,Hoenger G,Conen A,Recher M,Battegay M,Reddy ST,Hess C

    更新日期：2015-01-01 00:00:00

  • Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults.

    abstract：:The multicomponent meningococcal serogroup B vaccine, 4CMenB, has demonstrated effectiveness in preventing invasive MenB disease in infants and in controlling MenB outbreaks. The need for/timing of additional booster doses is not yet established. We reviewed eight studies that evaluated antibody persistence and booste...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2019.1627159

    authors： Martinón-Torres F,Nolan T,Toneatto D,Banzhoff A

    更新日期：2019-01-01 00:00:00

  • Immunization of children with secondary immunodeficiency.

    abstract：:The main causes of secondary immunodeficiency at a pediatric age include infectious diseases (mainly HIV infection), malignancies, haematopoietic stem cell or solid organ transplantation and autoimmune diseases. Children with secondary immunodeficiency have an increased risk of severe infectious diseases that could be...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2015.1039208

    authors： Esposito S,Prada E,Lelii M,Castellazzi L

    更新日期：2015-01-01 00:00:00

  • Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia.

    abstract：:Understanding motivators and barriers of health care worker (HCW) vaccination programs is important for determining strategies to improve uptake. The aim of this study was to explore key drivers and HCW decision making related to recommended vaccines and seasonal influenza vaccination programs. We used a qualitative a...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2016.1153204

    authors： Tuckerman JL,Shrestha L,Collins JE,Marshall HS

    更新日期：2016-07-02 00:00:00

  • Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis.

    abstract：:The prevalence of seasonal allergic rhinitis in the western world is high and increasing. Besides considerably affecting physical and psychosocial aspects of patients' lives, allergic rhinitis is often associated with allergic asthma and may aggravate this condition over time. Specific immunotherapy is currently the o...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.4161/hv.24631

    authors： Rosewich M,Lee D,Zielen S

    更新日期：2013-07-01 00:00:00

  • Noninvasive vaccination against infectious diseases.

    abstract：:The development of a successful vaccine, which should elicit a combination of humoral and cellular responses to control or prevent infections, is the first step in protecting against infectious diseases. A vaccine may protect against bacterial, fungal, parasitic, or viral infections in animal models, but to be effecti...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章,评审

    doi：10.1080/21645515.2018.1461296

    authors： Zheng Z,Diaz-Arévalo D,Guan H,Zeng M

    更新日期：2018-07-03 00:00:00

  • Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation.

    abstract：:DNA vaccination holds the potential to treat or prevent nearly any immunogenic disease, including cancer. To date, these vaccines have demonstrated limited immunogenicity in vivo due to the absence of a suitable delivery system which can protect DNA from degradation and improve transfection efficiencies in vivo. Recen...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2016.1248008

    authors： Cole G,McCaffrey J,Ali AA,McBride JW,McCrudden CM,Vincente-Perez EM,Donnelly RF,McCarthy HO

    更新日期：2017-01-02 00:00:00

  • Tolerogenic vaccine composited with islet-derived multipeptides and cyclosporin A induces pTreg and prevents Type 1 diabetes in murine model.

    abstract：:Regulatory T cells (Tregs) play a crucial role in the control of the initiation and progression of type 1 diabetes (T1D). Various immunological interventions including those to ex vivo expansion Tregs transfer, in vivo induction of peripherally derived Treg (pTreg) have been considered as promising approaches for T1D ...

    journal_title：Human vaccines & immunotherapeutics

    pub_type： 杂志文章

    doi：10.1080/21645515.2019.1616504

    authors： Zhou X,Zhang S,Yu F,Zhao G,Geng S,Yu W,Wang XY,Wang B

    更新日期：2020-01-01 00:00:00